WILMINGTON, Mass., 13 Nov. 2014. U.S. Transportation Security Administration (TSA) officials in Washington needed an effective method of detecting explosive materials at multiple airports across the U.S. They found their solution at Implant Sciences Corp. (OTCQB:IMSC), a high-technology supplier of systems and sensors for homeland security and defense markets in Wilmington, Mass. TSA officials have placed an initial order for 1,170 QS-B220 Desktop Explosive Trace Detectors and ancillary supplies.
The QS-B220 uses Ion Mobility Spectrometry (IMS) to detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. The QS-B220 combines a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal internal automatic calibration system.
"Receiving this order from the TSA is a goal that Implant Sciences has been driving towards for a number of years. Achieving it is a major milestone for the Company and a tribute to the ability and dedication of our employees. We are proud to help protect the traveling public in the United States and look forward to a long working relationship with the TSA," says Implant Sciences CEO Glenn D. Bolduc.
Implant Sciences develops and manufactures advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives. The company's commercial products have been sold across more than 50 countries worldwide. The Company's ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., STAC in France, the German Ministry of the Interior, and the Ministry of Public Safety in China.